Gadoxetic disodium is not metabolized by CYP enzymes.

Gadoxetic acid is indicated for the detection of focal liver lesions and provides information on the character of lesions in T1-wighted magnetic resonance imaging (MRI). It is for diagnostic use by intravenous administration only. Common side effects are nausea and headache.

Gadoxetate disodium is not metabolized. It is excreted in the urine and feces. Elimination half-life is 1 hour. It is highly water-soluble and less than 10% is bound to proteins in vivo.